Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.65% to 7,377.90.
Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd (ASX:MVF) share price look very tempting at these prices, writes Seneca’s Luke Laretive.
Monash IVF (ASX:MVF) shares are down 1% despite announcing that it is seeing a recovery in the IVF market.
Monash IVF Group Ltd (ASX:MVF) released its FY19 report this morning, and shareholders may be in for more pain after the announcement last week that sent the share price down 26%.
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 0.45% on Wednesday.
The Monash IVF Group Ltd (ASX:MVF) share price jumped nearly 5% yesterday after announcing the acquisition of another fertility clinic.
Monash IVF Group Ltd (ASX:MVF) has announced an acquisition to the market to grow its profit.
The Monash IVF Group Ltd (ASX:MVF) share price could fall after NSW Premier Gladys Berejiklian announced a $42 million package for IVF treatment.
Monash IVF Group Ltd (ASX:MVF) today released its half-year results to the market reporting its net profit after tax (NPAT) slumped 19.8% to $9.67 million.
